基于循证的儿科哮喘急性加重治疗在区域紧急医疗服务机构联盟中实施评估数据集

评估区域EMS联盟中儿科哮喘急性加重循证治疗实施效果的数据集,包含713例患者的表格数据。

Taylor & FrancisTaylor & Francis
DataCite Commons
2024-04-22 更新
浏览 15
表格Bronchodilatoremergency medical servicesimplementationpediatric asthmaRE-AIMsystemic corticosteroid
Evaluation of the implementation of evidence-based pediatric asthma exacerbation treatments in a regional consortium of emergency medical Services Agencies

基本信息

模态
表格
大小
0.000089149 GB
许可
CC BY 4.0
创建/更新时间
2024-04-22
版本
v1

资源简介

基于循证的儿科哮喘急性加重治疗在区域紧急医疗服务机构联盟中实施评估数据集

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 4 个文件、合计 89.15 KB,主题涵盖 Bronchodilator、emergency medical services、implementation、pediatric asthma、RE-AIM,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Evaluation of the implementation of evidence-based pediatric asthma exacerbation treatments in a regional consortium of emergency medical Services Agencies》。配套论文《Evaluation of the implementation of evidence-based pediatric asthma exacerbation treatments in a regional consortium of emergency medical Services Agencies》发表于 Journal of Asthma(2023),DOI:10.1080/02770903.2023.2280917。项目资助方:This study and Dr. Fishe’s activity on this study were supported by a career development award from NIH/NHLBI (K23HL149991). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.。源站首次发布:2023-11-11。

【数据内容】

源站原始描述:Asthma exacerbations are a frequent reason for pediatric emergency medical services (EMS) encounters. The objective of this study was to examine the implementation of evidence-based treatments for pediatric asthma in a regional consortium of EMS agencies. This retrospective study applied the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) implementation framework to data from an EMS agency consortium in the Cincinnati, Ohio region. The study analyzed one year before an o…

【数据结构与技术规格】

文件数 4 个,合计 89.15 KB。ijas_a_2280917_sm1953.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,14.63 KB。ijas_a_2280917_sm1952.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,13.51 KB。ijas_a_2280917_sm1926.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,28.56 KB。数据集 DOI:10.6084/m9.figshare.24547419.v1。

【主题与分类】

源站学科分类:Medicine、Microbiology、Genetics、Biotechnology、Immunology、Science Policy。主题标签:Bronchodilator、emergency medical services、implementation、pediatric asthma、RE-AIM、systemic corticosteroid。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Evaluation_of_the_implementation_of_evidence-based_pediatric_asthma_exacerbation_treatments_in_a_regional_consortium_of_emergency_medical_Services_Agencies/24547419

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Evaluation of the implementation of evidence-based pediatric asthma exacerbation treatments in a regional consortium of emergency medical Services Agencies. Taylor & Francis. Fishe, Jennifer N.; Crisp, Amy M.; Riney, Lauren; Bertrand, Andrew; Burcham, Shannon; Hendry, Phyllis; et al

【使用注意】

· 源站最后修改于 2024-04-22,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ijas_a_2280917_sm1953.docx" "https://ndownloader.figshare.com/files/43116852"
curl -L -o "ijas_a_2280917_sm1952.docx" "https://ndownloader.figshare.com/files/43116855"
curl -L -o "ijas_a_2280917_sm1926.docx" "https://ndownloader.figshare.com/files/43116858"
curl -L -o "ijas_a_2280917_sm1919.docx" "https://ndownloader.figshare.com/files/43116861"

文件清单

  • ijas_a_2280917_sm1953.docx(14.63 KB)
  • ijas_a_2280917_sm1952.docx(13.51 KB)
  • ijas_a_2280917_sm1926.docx(28.56 KB)
  • ijas_a_2280917_sm1919.docx(32.45 KB)

文件总体积 89.15 KB(源站 API 实测)。

数据说明

Asthma exacerbations are a frequent reason for pediatric emergency medical services (EMS) encounters. The objective of this study was to examine the implementation of evidence-based treatments for pediatric asthma in a regional consortium of EMS agencies.
This retrospective study applied the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) implementation framework to data from an EMS agency consortium in the Cincinnati, Ohio region. The study analyzed one year before an oral systemic corticosteroid (OCS) option was added to the agencies’ protocol, and five years after the protocol change. We constructed logistic regression models for the primary outcome of Reach, defined as the proportion of pediatric asthma patients who received a systemic corticosteroid. We modeled Maintenance (Reach measured monthly over time) using time series models.
A total of 713 patients were included, 133 pre- and 580 post-protocol change. In terms of Reach, 3% (n = 4) of eligible patients received a systemic corticosteroid pre-OCS versus 20% (n = 116) post-OCS. Multivariable modeling of Reach revealed the study period, EMS transport time, months since implementation of OCS, and number of bronchodilators administered by EMS as significant covariates for the administration of a systemic corticosteroid. For Maintenance, it took approximately two years to reach maximal administration of systemic corticosteroids.
Indicators of asthma severity and time since the protocol change were significantly associated with EMS administration of systemic corticosteroids to pediatric asthma patients. The two-year time for maximal Reach suggests further work is required to understand how to best implement evidence-based pediatric asthma treatments in EMS.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.24547419.v1(source: https://tandf.figshare.com/articles/dataset/Evaluation_of_the_implementation_of_evidence-based_pediatric_asthma_exacerbation_treatments_in_a_regional_consortium_of_emergency_medical_Services_Agencies/24547419)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案